In addition to indication benchmarks based on 18 years of historical drug development data, GlobalData also tracks the likelihood of phase change and approval scores for specific drugs. The attributes of the drug, the company, and its clinical trials play an important role in drug-specific PTSR and likelihood of approval.
BW-20507 Overview
BW-20507 is being developed to treat chronic hepatitis B virus (HBV) infection. The therapeutic candidate is administered as a solution by the subcutaneous route.
Argo Biopharma Australia Overview
Argo Biopharma Australia (Argo Biopharma) is a healthcare services provider specializing in research, development and other related services. Argo Biopharma is headquartered in Adelaide, South Australia, Australia.
For complete information on BW-20507 drug-specific PTSR and LoA scores, purchase the report here.
Desde
The gold standard in business intelligence.
GlobalData’s unparalleled proprietary data combines expertise with cutting-edge technology, allowing you to decipher what’s happening in the market. You can make smarter decisions and gain a future-proof advantage over your competitors.